Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
9.19
+0.02 (0.22%)
Oct 29, 2026, 10:59 AM EDT - Market open
Alpha Cognition Employees
Alpha Cognition had 71 employees as of December 31, 2025. The number of employees increased by 14 or 24.56% compared to the previous year. That makes Alpha Cognition the 33,291st largest employer in the world and 4,378th in the United States.
Employees
71
Change (1Y)
14
Growth (1Y)
24.56%
Revenue / Employee
$214,940
Profits / Employee
-$295,962
Market Cap
200.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 71 | 14 | 24.56% | 71 | 0 |
| Dec 31, 2024 | 57 | - | - | 52 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Zentalis Pharmaceuticals | 106 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| Precision BioSciences | 67 |
| Sionna Therapeutics | 59 |
| Korro Bio | 57 |
ACOG News
- 16 days ago - Alpha Cognition announces publication of US patent application for ZUNVEYL - TheFly
- 16 days ago - Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL® - Business Wire
- 23 days ago - Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress - Business Wire
- 26 days ago - Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Alpha Cognition announces CONVERGE RWE on ZUNVEYL - TheFly
- 4 weeks ago - Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care - Business Wire
- 5 weeks ago - Alpha Cognition management to meet virtually with B. Riley - TheFly
- 2 months ago - Alpha Cognition initiated with a Buy at B. Riley - TheFly